Covid Cash: Pfizer and Moderna Set to Reap Billions More as FDA Approves Boosters for Immunocompromised
Excerpt: by Megan Redshaw August 13, 2021 in Business The U.S. Food and Drug Administration (FDA) Thursday authorized a third dose of Pfizer-BioNTech and Moderna COVID vaccines for people with compromised immune systems. Neither vaccine has yet received full FDA approval, and neither has completed late-stage clinical trials proving a third dose will boost immunity or work against COVID variants. The amended Emergency Use Authorization ... Read more